Primary hyperaldosteronism in a patient with end-stage renal disease

被引:5
作者
Kazory, Amir
Weiner, I. David
机构
[1] Univ Florida, Div Nephrol, Gainesville, FL 32610 USA
[2] N Florida S Georgia Vet Hlth Syst, Nephrol & Hypertens Sect, Gainesville, FL 32610 USA
关键词
aldosterone; end-stage renal disease; haemodialysis; hypertension;
D O I
10.1093/ndt/gfl702
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:917 / 919
页数:3
相关论文
共 20 条
[1]  
BASTL CP, 1988, AM J PHYSIOL, V255, pF1235, DOI 10.1152/ajprenal.1988.255.6.F1235
[2]   Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension [J].
Blacher, J ;
Amah, G ;
Girerd, X ;
Kheder, A ;
Ben Mais, H ;
London, GM ;
Safar, ME .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (12) :1326-1334
[3]   EXTRARENAL RENIN AND BLOOD-PRESSURE REGULATION - AN ALTERNATIVE VIEWPOINT [J].
CAMPBELL, DJ .
AMERICAN JOURNAL OF HYPERTENSION, 1989, 2 (04) :266-275
[4]  
FRIERDICH G, 1998, AM SOC HYP 13 SCI M
[5]   Mechanisms of mineralocorticoid action [J].
Fuller, PJ ;
Young, MJ .
HYPERTENSION, 2005, 46 (06) :1227-1235
[6]   Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients [J].
Gross, E ;
Rothstein, M ;
Dombek, S ;
Juknis, HI .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) :94-101
[7]   Hemodialysis-associated hypertension:: Pathophysiology and therapy [J].
Hörl, MP ;
Hörl, WH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :227-244
[8]  
Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170
[9]   Primary aldosteronism and hypertensive disease [J].
Mosso, L ;
Carvajal, C ;
González, A ;
Barraza, A ;
Avila, F ;
Montero, J ;
Huete, A ;
Gederlini, A ;
Fardella, CE .
HYPERTENSION, 2003, 42 (02) :161-165
[10]   Diagnosis of primary aldosteronism: from screening to subtype differentiation [J].
Mulatero, P ;
Dluhy, RG ;
Giacchetti, G ;
Boscaro, M ;
Veglio, F ;
Stewart, PM .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (03) :114-119